507 results

opportunity
Value

Posted on 22.10.2010

Doors of opportunity open for medtech

The build up to last week’s MedTech Forum in Brussels was frenetic for the Eucomed team and left us all exhausted for the weekend. The new week brings time for reflection and some satisfaction at a job well done. It was always our objective to generate a high level of informed debate and bring stakeholders together from different perspectives.

By John Wilkinson Former Chief Executive of Eucomed

autumn
Business Value

Posted on 22.10.2010

Fall leaves are dropping and hopes of reform too?

A year on and the mood music in Washington is very different. My return to this beautiful city, where fall colours are emerging in their full majesty, has seen a very different atmosphere from a year ago when the Obama health reforms were on their way and universal coverage seemed a very real probability. The […]

By John Wilkinson Former Chief Executive of Eucomed

globalharmonisation
Global Regulation

Posted on 21.10.2010

Can we move global harmonisation to the next level?

Proponents of greater regulatory harmonisation and cooperation will have been heartened by FDA chief Peggy Hamburg’s comments at the Advamed 2010 conference on Wednesday 20 October. She was quick to acknowledge that, in a changing world with vastly increased trade, the FDA could not continue to operate on an old-fashioned model designed for a time […]

By John Wilkinson Former Chief Executive of Eucomed

wireless-tech
Digital

Posted on 06.10.2010

Wiring up wireless enabled healthcare

Yesterday afternoon I was fortunate enough to be invited to participate in a round table discussion organised by Motorola as part of the EU Open Days conference organised by the Committee for the Regions. Entitled ‘ EU Wide Patient Safety – A Roundtable to demonstrate ways of overcoming barriers to adoption in healthcare using innovative […]

By John Wilkinson Former Chief Executive of Eucomed

transparent
Ethics

Posted on 01.10.2010

Adam Smith, corruption and biases

The 7th European Healthcare Fraud & Corruption Network conference took place in Brussels at the end of September and featured high level speakers and experts. The event proved to be an ideal platform for discussing a number of topics of relevance to all the stakeholders in the healthcare system. The “Conflicts of Interest” session was […]

By Aline Lautenberg MedTech Europe, General Counsel - Director Legal & Compliance

telehealth
Digital

Posted on 29.09.2010

Telemedicine – Never knowingly over sold

‘Never knowingly under sold’ is a slogan that one major UK retailer has been using more or less continuously since 1925. I have never quite understood what it means. E-heath and telemedicine have been touted as the key to disruptive change in healthcare for a very long time. I recall spending an entertaining four days […]

By John Wilkinson Former Chief Executive of Eucomed

wave2
Global

Posted on 23.09.2010

More EU needed to ride the Chinese wave

The occasion of the annual visit of the European Chamber of Commerce in Europe afforded me the rare opportunity to meet both a group of senior industry leaders from China and the Chinese ambassador to the EU, and his trade officials. What was clear from this excellent opportunity to gain first hand insights on the […]

By John Wilkinson Former Chief Executive of Eucomed

IT
Access Digital

Posted on 23.06.2010

The potential of IT to transform healthcare

Sitting on the tram this morning, flicking through my e-mails and preparing for the busy day ahead, I began to muse on the incredible impact that information technology has had on my life. Doing this sort of communication was inconceivable even when I had my first management role. My own personal secretary was highly skilled […]

By John Wilkinson Former Chief Executive of Eucomed

scale2
Access Value

Posted on 01.06.2010

The real worth of medical technologies

The blogosphere has been driven into a foment over the last week or so by a paper by Groeneveld et al entitled ‘Increasing Use of Cardiovascular Devices and Rising Health Costs’. Its conclusions are interesting but, I suggest, not conclusive of anything which should prompt policy makers to ask further questions. Discounted for inflation the […]

By John Wilkinson Former Chief Executive of Eucomed